Table 8 Effect of NAR and NAR-HNPs on cortical monoamines and metabolites in experimental rats.

From: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway

Groups

Parameters

Cortex (μg/g)

NE

5-HT

5-HTAA

DA

DOPAC

Normal

0.34b ± 0.01

0.40b ± 0.05

0.07b ± 0.00

0.63b ± 0.01

0.10b ± 0.00

Free NAR

0.36b ± 0.03

0.37b ± 0.02

0.07b ± 0.00

0.58b ± 0.02

0.10b ± 0.01

NAR-HNPs

0.31b ± 0.02

0.36b ± 0.03

0.07b ± 0.00

0.55b ± 0.01

0.10b ± 0.00

Control STZ

0.18acd ± 0.01

0.26 acd ± 0.01

0.09 acd ± 0.00

0.43 acd ± 0.02

0.13 acd ± 0.01

STZ + unloaded HNPs

0.18 acd ± 0.01

0.27 acd ± 0.03

0.10 acd ± 0.01

0.42 acd ± 0.04

0.13 acd ± 0.01

STZ + NAR (50 mg/kg)

0.25abd ± 0.02

0.37b ± 0.03

0.07 bd ± 0.00

0.57 bd ± 0.04

0.11bd ± 0.00

STZ + NAR-HNPs (50 mg/kg)

0.37bc ± 0.01

0.44b ± 0.01

0.08 bc ± 0.00

0.68bc ± 0.04

0.10 bc ± 0.00

STZ + NAR (50 mg/kg) + GW9662

0.18acd ± 0.00

0.27 acd ± 0.00

0.09 acd ± 0.01

0.41acd ± 0.01

0.14 acd ± 0.00

  1. Results are stated as means ± SEM (n = 6), a vs normal group, b vs control STZ group, c vs STZ + NAR (50 mg/kg), d vs STZ + NAR-HNPs (50 mg/kg) at p < 0.05. NAR, naringenin; STZ, streptozotocin; NAR-HNPs, naringenin- loaded hybridized nanovesicles.